Putnam BioRevolution ETF
Not enough financial coverage to compute a composite score for SYNB. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Company
The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on "biology revolution" companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified.
- IPO
- 2022
- HQ
- US
Price Chart
Valuation
- Market Cap
- $5.29M
- Div Yield
- 0.68%
Performance & Tape
- 52W High
- $31.73
- 52W Low
- $24.57
- 50D MA
- $30.62
- 200D MA
- $29.10
- Beta
- 1.07
- Avg Volume
- 850
Get TickerSpark's AI analysis on SYNB
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SYNB Coverage
We haven't published any research on SYNB yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SYNB Report →